From the publishers of JADPRO
CAR T-Cell Therapy
Resource Center
Menu
Resources
Videos
Videos
Fast Facts
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Fast Facts #11: Outpatient CAR T-Cell Therapy
Last Updated: Tuesday, April 26, 2022
Advertisement
News & Literature Highlights
Cure
Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients With Multiple Myeloma
Transplantation and Cellular Therapy
ASTCT, CIBMTR, and ESBMT Clinical Practice Recommendations for Transplantation and Cellular Therapies
Journal of Blood Medicine
Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma
Biology of Blood and Marrow Transplantation
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
Expert Review of Anti-Infective Therapy
CAR-T Cell Therapy and Infection: A Review
Blood Advances
Comparison of 2-Year Outcomes With CAR T Cells (ZUMA-1) Versus Salvage Chemotherapy in Refractory Large B-Cell Lymphoma
The ASCO Post
Early-Phase Study Explores CAR T-Cell Therapy for Relapsed or Refractory B-Cell Lymphoma
Nature Reviews Clinical Oncology
Engineering Strategies to Overcome the Current Roadblocks in CAR T Cell Therapy
Journal of Clinical Oncology
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Journal of the Advanced Practitioner in Oncology
CAR T-Cell Therapy: Adverse Events and Management
Advertisement
Case Studies
CAR T-cell Infusion in an Outpatient Setting: An Ideal Option for Selected Patients When Available
B-Cell Aplasia, Hypogammaglobulinemia Can Result in Serious, Life-Threatening Infections
Neurologic Toxicity Post-CAR T-Cell Therapy and CRS: Differentiating Symptoms and Individual Management
Fast Facts
Fast Facts #12: BCMA Targets
Advertisement
Quizzes
Test your knowledge of CAR T-cell infusion in an outpatient setting
Test your knowledge on B-cell aplasia
Test your knowledge on ICANS management in patients receiving CAR T-cell therapy